EKF Diagnostics Holdings plc announced the launch of its new and enhanced Biosen C-Line, an industry leading benchtop glucose and lactate analyzer within its Point of Care range, in response to customer demands for greater connectivity options and improved usability. The Biosen C-Line (the "Biosen") is an easy-to-use, POC analyzer which accurately measures glucose and lactate levels in healthcare and sports performance. The Biosen is used by clinical professionals in both primary and secondary care settings around the world to provide fast and accurate glucose analysis for the detection and management of diabetes, a chronic condition which is expected to affect 1.31 billion people worldwide by 2050.

The Biosen is also the first choice for elite sports professionals, including international football and Olympic teams, to measure lactate production during training, which provides valuable insights into athletes' metabolic responses during training and competition to help achieve peak performance. The updated Biosen range uses the same proven technology as its predecessor to provide precise and rapid measurements of glucose and lactate levels in whole blood, plasma and serum with just one test. The new version has been enhanced with improved connectivity, and is fully compatible with EKF Link, a middleware solution for healthcare providers to manage their POC analyzers on one centralised platform to enable the real-time remote management of data.

EKF Link is a fast and secure method for connecting POC devices to hospital and laboratory IT systems, enabling the safe transfer of data from the analyzer to the hospital or laboratory database for subsequent processing. Integration of technology systems and advanced connectivity is becoming increasingly important to healthcare providers and laboratories around the world, as they look to improve resource utilisation and efficiencies. The addition of EKF Link to the Company's POC portfolio has opened up a number of new tender opportunities around the world, including the Hong Kong and Thai Red Cross partnerships and will continue to aid the Company's growth in the blood bank market globally.